Start Over

A case report of fungemia due to Kodamaea ohmeri

Authors :: G. Cadelis
M. Nicolas
K. Diallo
Fabien Gandon
J. C. Gallois
B. Lefevre
B. Hoen
Bodescot, Myriam
Department of Infective and Tropical Diseases, Dermatology and Internal Medicine [Pointe-à-Pitre, Guadeloupe]
CHU Pointe-à-Pitre/Abymes [Guadeloupe]
Lung diseases unit [Pointe-à-Pitre, Guadeloupe]
Laboratory of bacteriology, parasitology and mycology [Pointe-à-Pitre, Guadeloupe]
Centre d’Investigation Clinique [Pointe-à-Pitre, Guadeloupe]
Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe]
Université des Antilles - UFR des sciences médicales Hyacinthe Bastaraud (UA UFR SM)
Université des Antilles (UA)
Source :: BMC Infectious Diseases, BMC Infectious Diseases, BioMed Central, 2019, 19 (1), pp.570. ⟨10.1186/s12879-019-4208-8⟩, BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-3 (2019)
Publication Year :: 2019
Publisher :: BioMed Central, 2019.
Abstract: International audience; BACKGROUND:Kodamaea ohmeri is a yeast is frequently mistaken for Candida, which belongs to the same family. This micro-organism has been reported to cause life-threatening infections in humans.CASE PRESENTATION:A 81-year-old woman developed a severe fungemic pulmonary infection due to Kodamaea ohmeri that was identified from bronchoalveolar fluid and blood cultures, which is unusual in immunocompetent patients. Because K. ohmeri was first wrongly identified as Candida albicans, the patient inadequately received caspofungin, which was clinically ineffective, especially as the strain was resistant to echinocandins. Clinical cure was obtained after treatment was switched to voriconazole.CONCLUSIONS:An increasing number of serious infections due to K. ohmeri has been reported in the literature, but the correct identification of this micro-organism remains difficult.